Skip to main content
Signal8
Jellison William R profile photo

William R. Jellison

CIK: 0001189883

Transaction Breakdown

Open Market Buys (P)3 (17.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (5.9%)

Derivative conversions

Awards (A)13 (76.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

AVIENT CORP logo
AVNT

AVIENT CORP

Director
Telix Pharmaceuticals Ltd logo
TLX

Telix Pharmaceuticals Ltd

Director
Medtronic plc logo
MDT

Medtronic plc

Director
MASIMO CORP logo
MASI

MASIMO CORP

Director
Anika Therapeutics, Inc. logo
ANIK

Anika Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (17 total)

  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Sep 30, 2026
    Award(A)
    Direct
    958 shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Jun 30, 2026
    Award(A)
    Direct
    1K shares-
  • Medtronic plc logo
    MDT

    Medtronic plc

    Apr 27, 2026
    Award(A)
    Direct
    1.4K shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Mar 31, 2026
    Award(A)
    Direct
    1.1K shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Dec 31, 2025
    Award(A)
    Direct
    1.2K shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Sep 30, 2025
    Award(A)
    Direct
    1.2K shares-
  • Medtronic plc logo
    MDT

    Medtronic plc

    Aug 25, 2025
    Purchase(P)
    Direct
    2.5K shares at avg. $92.37$231K
  • Medtronic plc logo
    MDT

    Medtronic plc

    Aug 22, 2025
    Purchase(P)
    Direct
    2.5K shares at avg. $92.73$232K
  • MASIMO CORP logo
    MASI

    MASIMO CORP

    Aug 11, 2025
    Purchase(P)
    Direct
    3K shares at avg. $145.98$438K
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Jun 30, 2025
    Award(A)
    Direct
    1.2K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Jun 20, 2025
    Award(A)
    Direct
    14.2K shares-
  • MASIMO CORP logo
    MASI

    MASIMO CORP

    Apr 29, 2025
    Exercise(M)

    Restricted Stock Units

    Direct
    1.8K shares-
  • MASIMO CORP logo
    MASI

    MASIMO CORP

    Apr 29, 2025
    Award(A)
    Direct
    1.8K shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Mar 31, 2025
    Award(A)
    Direct
    1.1K shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Dec 31, 2024
    Award(A)
    Direct
    955 shares-
  • AVIENT CORP logo
    AVNT

    AVIENT CORP

    Sep 30, 2024
    Award(A)
    Direct
    775 shares-
  • MASIMO CORP logo
    MASI

    MASIMO CORP

    Sep 19, 2024
    Award(A)

    Restricted Stock Units

    Direct
    1.8K shares-

1-17 of 17

About Jellison William R

Jellison William R (SEC CIK 0001189883) files insider reports with the SEC as Director of AVIENT CORP (AVNT), Director of Telix Pharmaceuticals Ltd (TLX) and Director of Medtronic plc (MDT). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 18 ownership filings by Jellison William R (3 Form 3, 15 Form 4), filed between Sep 23, 2024 and Oct 2, 2026. Those filings report 17 transactions, from Sep 19, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jellison William R's filings is in AVON LAKE, OH.

Recent filings by Jellison William R

  • Sep 30, 2026: Grant or award of AVNT shares (Form 4, code A).
  • Jun 30, 2026: Grant or award of AVNT shares (Form 4, code A).
  • Apr 27, 2026: Grant or award of MDT shares (Form 4, code A).
  • Mar 31, 2026: Grant or award of AVNT shares (Form 4, code A).
  • Dec 31, 2025: Grant or award of AVNT shares (Form 4, code A).

Other insiders filing for AVIENT CORP (AVNT)

How to read Form 4 transaction codes